Stephen Mandel Amicus Therapeutics, Inc. Transaction History
Lone Pine Capital LLC
- $12.7 Billion
- Q1 2024
Shares
2 transactions
Others Institutions Holding FOLD
# of Institutions
273Shares Held
325MCall Options Held
841KPut Options Held
353K-
Vanguard Group Inc Valley Forge, PA28.2MShares$280 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY28.1MShares$278 Million6.94% of portfolio
-
Avoro Capital Advisors LLC New York, NY27.4MShares$272 Million3.89% of portfolio
-
Black Rock Inc. New York, NY22.8MShares$227 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA18.8MShares$187 Million0.04% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $2.78B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...